BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 15337694)

  • 1. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.
    Boekholdt SM; Kuivenhoven JA; Wareham NJ; Peters RJ; Jukema JW; Luben R; Bingham SA; Day NE; Kastelein JJ; Khaw KT
    Circulation; 2004 Sep; 110(11):1418-23. PubMed ID: 15337694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.
    Boekholdt SM; Peters RJ; Hack CE; Day NE; Luben R; Bingham SA; Wareham NJ; Reitsma PH; Khaw KT
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1503-8. PubMed ID: 15178568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides.
    Borggreve SE; Hillege HL; Dallinga-Thie GM; de Jong PE; Wolffenbuttel BH; Grobbee DE; van Tol A; Dullaart RP;
    Eur Heart J; 2007 Apr; 28(8):1012-8. PubMed ID: 17409111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
    Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin.
    Marschang P; Sandhofer A; Ritsch A; Fiŝer I; Kvas E; Patsch JR
    J Intern Med; 2006 Aug; 260(2):151-9. PubMed ID: 16882279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
    Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.
    Moriyama Y; Okamura T; Inazu A; Doi M; Iso H; Mouri Y; Ishikawa Y; Suzuki H; Iida M; Koizumi J; Mabuchi H; Komachi Y
    Prev Med; 1998; 27(5 Pt 1):659-67. PubMed ID: 9808796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
    Boekholdt SM; Sacks FM; Jukema JW; Shepherd J; Freeman DJ; McMahon AD; Cambien F; Nicaud V; de Grooth GJ; Talmud PJ; Humphries SE; Miller GJ; Eiriksdottir G; Gudnason V; Kauma H; Kakko S; Savolainen MJ; Arca M; Montali A; Liu S; Lanz HJ; Zwinderman AH; Kuivenhoven JA; Kastelein JJ
    Circulation; 2005 Jan; 111(3):278-87. PubMed ID: 15655129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P; Mensink RP; Hornstra G
    Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesteryl ester transfer protein in metabolic syndrome.
    Sandhofer A; Kaser S; Ritsch A; Laimer M; Engl J; Paulweber B; Patsch JR; Ebenbichler CF
    Obesity (Silver Spring); 2006 May; 14(5):812-8. PubMed ID: 16855190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V.
    Seiler S; Schlitt A; Jiang XC; Ulrich C; Blankenberg S; Lackner KJ; Girndt M; Werdan K; Buerke M; Fliser D; Heine GH
    Nephrol Dial Transplant; 2008 Nov; 23(11):3599-604. PubMed ID: 18503096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients.
    Yilmaz H; Isbir T; Agachan B; Karaali ZE
    Cell Biochem Funct; 2005; 23(1):23-8. PubMed ID: 15386541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of plasma cholesteryl ester transfer protein activity and polymorphism with coronary artery disease extent in Tunisian type II diabetic patients.
    Chaaba R; Hammami S; Attia N; Smaoui M; Masmoudi AS; Mahjoub S; Ben Hamda K; Hammami M
    Clin Biochem; 2005 Apr; 38(4):373-8. PubMed ID: 15766738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase activities in hispanic and anglo postmenopausal women: associations with total and regional body fat.
    Greaves KA; Going SB; Fernandez ML; Milliken LA; Lohman TG; Bassford T; McNamara DJ
    Metabolism; 2003 Mar; 52(3):282-9. PubMed ID: 12647264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
    Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL;
    Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in the cholesteryl ester transfer protein (CETP) gene does not influence individual plasma cholesterol response to changes in the nature of dietary fat.
    Aitken WA; Chisholm AW; Duncan AW; Harper MJ; Humphries SE; Mann JI; Murray Skeaff C; Sutherland WH; Wallace AJ; Williams SM
    Nutr Metab Cardiovasc Dis; 2006 Jul; 16(5):353-63. PubMed ID: 16829344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients.
    Grion CM; Cardoso LT; Perazolo TF; Garcia AS; Barbosa DS; Morimoto HK; Matsuo T; Carrilho AJ
    Eur J Clin Invest; 2010 Apr; 40(4):330-8. PubMed ID: 20486994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
    Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.